by Sandra Gidley, Chair, English Pharmacy Board
Early last week three separate reports from the Care Quality Commission, Public Health England and NHS Improving Quality were released and painted a poor and depressing picture of the level of prescribing of antipsychotics and antidepressants in those with learning disabilities.
Following the release of the reports, I co-signed, on behalf of the RPS English Pharmacy Board, a letter from NHS England stating that the scale of the problem was unacceptable and that an emergency summit was being arranged to agree how to tackle the problem. The letter was also signed by the Royal College of Psychiatrists and the Royal College of Nursing. Read more Prescribing for people with learning disabilities must change